Aventis Pasteur S.A.
17Patents
2Active
17Granted
34Portfolio score
Filing activity: Sep 9, 1997 → Jan 9, 2008 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6472506B1 | Polysaccharide-peptide-conjugates | Human Necessities | 45 | Expired |
| US6780421B1 | Adjuvant for a vaccine composition | Chemistry; Metallurgy | 36 | Expired |
| US6610308B1 | Immunostimulant emulsion | Human Necessities | 34 | Expired |
| US6596861B1 | Method for the reductive amination of polysaccharides | Emerging Cross-Sectional Technologies | 18 | Expired |
| US6664049B1 | Method and device for cell lysis | Chemistry; Metallurgy | 16 | Expired |
| US7122094B2 | Method and apparatus for sterile connection between two flexible tubes | Performing Operations; Transporting | 7 | Expired |
| US6472159B1 | Use of an amphipathic compound for providing an adjuvant to a subunit vaccine | Chemistry; Metallurgy | 6 | Expired |
| US7812006B2 | Conjugates obtained by reductive amination of the pneumococcus serotype 5 capsular polysaccharide | Human Necessities | 6 | Active |
| US7404960B2 | Multivalent vaccine composition having increased stability of capsular polysaccharide | Emerging Cross-Sectional Technologies | 3 | Expired |
| US6982088B2 | Vaccine composition and stabilization method using high molecular weight PVP | Emerging Cross-Sectional Technologies | 3 | Expired |
| US6641816B1 | Use of poxviruses as enhancer of specific immunity | Chemistry; Metallurgy | 3 | Expired |
| US7056519B2 | Methods for inducing HIV-neutralizing antibodies | Chemistry; Metallurgy | 1 | Expired |
| US7767658B2 | Vaccine composition | Emerging Cross-Sectional Technologies | 0 | Active |
| US6821723B2 | GP41 antigen | Chemistry; Metallurgy | 0 | Expired |
| US7320874B2 | Assaying the teichoic acids of gram+ bacteria | Emerging Cross-Sectional Technologies | 0 | Expired |
| US6737067B1 | Trimer of HIV env gene expression product | Chemistry; Metallurgy | 0 | Expired |
| US6861253B2 | Polypeptide inducing antibodies neutralizing HIV | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.